Last10K.com

Stealth Biotherapeutics Corp (MITO) SEC Filing 6-K Foreign Issuer report for the period ending Monday, March 4, 2019

Stealth Biotherapeutics Corp

HISTORY TOOLS
CIK: 1696396 Ticker: MITO

View differences made from one to another to evaluate Stealth Biotherapeutics Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Stealth Biotherapeutics Corp.

Continue

Assess how Stealth Biotherapeutics Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Stealth Biotherapeutics Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Stealth Biotherapeutics Corp provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Exhibit 99.3: Additional Exhibits
Ticker: MITO
CIK: 1696396
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001193125-19-062828
Submitted to the SEC: Mon Mar 04 2019 9:09:03 PM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Monday, March 4, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/mito/0001193125-19-062828.htm